172 related articles for article (PubMed ID: 31308693)
21. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
[TBL] [Abstract][Full Text] [Related]
22. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
23. A Ras-LSD1 axis activates PI3K signaling through PIK3IP1 suppression.
Lee K; Kitagawa M; Liao PJ; Virshup DM; Lee SH
Oncogenesis; 2020 Jan; 9(1):2. PubMed ID: 31900384
[TBL] [Abstract][Full Text] [Related]
24. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
[TBL] [Abstract][Full Text] [Related]
25. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
27. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin.
Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S
Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676
[TBL] [Abstract][Full Text] [Related]
28. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
29. Na+/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma.
Ariyoshi Y; Shiozaki A; Ichikawa D; Shimizu H; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
Oncotarget; 2017 Jan; 8(2):2209-2223. PubMed ID: 27902974
[TBL] [Abstract][Full Text] [Related]
30. Gambogic acid affects ESCC progression through regulation of PI3K/AKT/mTOR signal pathway.
Yu J; Wang W; Yao W; Yang Z; Gao P; Liu M; Wang H; Chen S; Wang D; Wang W; Sun G
J Cancer; 2020; 11(19):5568-5577. PubMed ID: 32913452
[TBL] [Abstract][Full Text] [Related]
31. Esophageal squamous cell carcinoma transcriptome reveals the effect of
Nicolau-Neto P; Da Costa NM; de Souza Santos PT; Gonzaga IM; Ferreira MA; Guaraldi S; Moreira MA; Seuánez HN; Brewer L; Bergmann A; Boroni M; Mencalha AL; Kruel CDP; Lima SCS; Esposito D; Simão TA; Pinto LFR
Oncotarget; 2018 Mar; 9(24):16634-16647. PubMed ID: 29682174
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma.
Wang SQ; Wang X; Zheng K; Liu KS; Wang SX; Xie CH
Biochem Biophys Res Commun; 2017 Nov; 493(1):534-541. PubMed ID: 28867195
[TBL] [Abstract][Full Text] [Related]
33. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
[TBL] [Abstract][Full Text] [Related]
34. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
35. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
36. WTAP promotes proliferation of esophageal squamous cell carcinoma via m
Zou J; Ma Q; Gao C; Yang M; Wen J; Xu L; Guo X; Zhong X; Duan Y
Cancer Sci; 2024 May; ():. PubMed ID: 38746998
[TBL] [Abstract][Full Text] [Related]
37. Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.
Lu Z; Wang J; Zheng Y; Yang S; Liu M; Chen X; Wang C; Hou G
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725440
[TBL] [Abstract][Full Text] [Related]
38. Osthole inhibits the PI3K/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma.
Zhu X; Li Z; Li T; Long F; Lv Y; Liu L; Liu X; Zhan Q
Biomed Pharmacother; 2018 Jun; 102():502-509. PubMed ID: 29579711
[TBL] [Abstract][Full Text] [Related]
39. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide ChIP-seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells.
Hoshino I; Takahashi M; Akutsu Y; Murakami K; Matsumoto Y; Suito H; Sekino N; Komatsu A; Iida K; Suzuki T; Inoue I; Ishige F; Iwatate Y; Matsubara H
Oncol Lett; 2019 Jul; 18(1):872-881. PubMed ID: 31289565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
